Antifungal drugs: Special problems treating central nervous system infections

Loading...
Thumbnail Image

Date

2019-12-01

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

63
views
30
downloads

Citation Stats

Abstract

© 2019 by the author. Licensee MDPI, Basel, Switzerland. Treating fungal infections in the central nervous system (CNS) remains a challenge despite the availability of new antifungal agents. Therapy is limited by poor understanding of the kinetic properties of antifungal drugs in the CNS compounded by lack of data for many agents. In some cases, clinical response rates do not correspond to data on drug concentrations in the cerebral spinal fluid and/or brain parenchyma. In order to better characterize the use of antifungal agents in treating CNS infections, a review of the essential principles of neuroPK are reviewed. Specific data regarding antifungal drug concentrations in the cerebral spinal fluid and brain tissue are described from human data where available. Alternative dosing regimens and the role of antifungal drug concentration monitoring in treating fungal infections in the CNS are also discussed. Having a better understanding of these key concepts will help guide clinicians in determining the best treatment courses for patients with these devastating infections.

Department

Description

Provenance

Subjects

Citation

Published Version (Please cite this version)

10.3390/jof5040097

Publication Info

Ashley, ED (2019). Antifungal drugs: Special problems treating central nervous system infections. Journal of Fungi, 5(4). pp. 97–97. 10.3390/jof5040097 Retrieved from https://hdl.handle.net/10161/19569.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.